CIBC World Market
HZNP

CIBC World Market’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

CIBC World Market’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-11,001
Closed -$1.27M – 1337
2023
Q3 		$1.27M Hold
11,001
– – ﹤0.01% 683
2023
Q2 		$1.13M Sell
11,001
-500
-4% -$52.8K ﹤0.01% 733
2023
Q1 		$1.25M Sell
11,501
-2,150
-16% -$238K ﹤0.01% 695
2022
Q4 		$1.55M Sell
13,651
-200
-1% -$16.6K 0.01% 643
2022
Q3 		$857K Sell
13,851
-829
-6% -$57.9K ﹤0.01% 754
2022
Q2 		$1.17M Sell
14,680
-600
-4% -$56.8K ﹤0.01% 684
2022
Q1 		$1.61M Sell
15,280
-159
-1% -$15.5K 0.01% 632
2021
Q4 		$1.66M Buy
15,439
+119
+0.8% +$13K ﹤0.01% 654
2021
Q3 		$1.68M Buy
15,320
+255
+2% +$26.5K 0.01% 647
2021
Q2 		$1.41M Buy
15,065
+201
+1% +$18.5K ﹤0.01% 705
2021
Q1 		$1.37M Buy
14,864
+9,280
+166% +$783K ﹤0.01% 688
2020
Q4 		$408K Sell
5,584
-7,601
-58% -$565K ﹤0.01% 1005
2020
Q3 		$1.02M Buy
13,185
+8,725
+196% +$600K ﹤0.01% 641
2020
Q2 		$248K Buy
+4,460
New +$191K ﹤0.01% 969
2019
Q2 		– Sell
-21,075
Closed -$557K – 1276
2019
Q1 		$557K Buy
+21,075
New +$499K ﹤0.01% 826

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

CIBC World Market's HZNP Position: Q4 2023 in Review

CIBC World Market sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 11,001 shares — an estimated $1.27M sold.

CIBC World Market first reported a position in HZNP in Q1 2019 and held it in 15 quarters. The position peaked at $1.68M in Q3 2021. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • CIBC World Market reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • CIBC World Market sold 11,001 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $1.27M.
  • CIBC World Market first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2019 and held it in 15 quarters.
  • CIBC World Market's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $1.68M in Q3 2021.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on CIBC World Market's 13F filing for Q4 2023, filed 13 Feb 2024.